Hereditary optic atrophy
RecruitingA study testing lenadogene nolparvovec gene therapy injections into the eye to improve vision in patients with ND4 Leber Hereditary Optic Neuropathy
A study testing lenadogene nolparvovec gene therapy injections into the eye to improve vision in patients with ND4 Leber Hereditary Optic Neuropathy
- Disease:Hereditary optic atrophy
- Substances:Lenadogene nolparvovec
France- Participants:0–17 years · 18–64 years · 65+ years
- Substances:Lenadogene nolparvovec
- Sponsor:Gensight Biologics











